The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction
Open accessAbstract
BACKGROUND Vasopressor agents could have certain specific effects in patients with cardiogenic shock (CS) after myocardial infarction, which may influence outcome. Although norepinephrine and epinephrine are currently the most commonly used agents, no randomized trial has compared their effects, and intervention data are lacking. OBJECTIVES The goal of this paper was to compare in a prospective, double-blind, multicenter, randomized study, the efficacy and safety of epinephrine and norepinephrine in patients with CS after acute myocardial infarction. METHODS The primary efficacy outcome was cardiac index evolution, and the primary safety outcome was the occurrence of refractory CS. Refractory CS was defined as CS with sustained hypotension, end-organ hypoperfusion and hyperlactatemia, and high inotrope and vasopressor doses. RESULTS Fifty-seven patients were randomized into 2 study arms, epinephrine and norepinephrine. For the primary efficacy endpoint, cardiac index evolution was similar between the 2 groups (p = 0.43) from baseline (H0) to H72. For the main safety endpoint, the observed higher incidence of refractory shock in the epinephrine group (10 of 27 [37%] vs. norepinephrine 2 of 30 [7%]; p = 0.008) led to early termination of the study. Heart rate increased significantly with epinephrine from H2 to H24 while remaining unchanged with norepinephrine (p < 0.0001). Several metabolic changes were unfavorable to epinephrine compared with norepinephrine, including an increase in cardiac double product (p = 0.0002) and lactic acidosis from H2 to H24 (p < 0.0001). CONCLUSIONS In patients with CS secondary to acute myocardial infarction, the use of epinephrine compared with norepinephrine was associated with similar effects on arterial pressure and cardiac index and a higher incidence of refractory shock. (Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock [OptimaCC]; NCT01367743).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citationIntraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Thiele, H., Zeymer, U., Neumann, F.-J., Ferenc, M., Olbrich, H.-G., Hausleiter, J., Richardt, G., Hennersdorf, M., Empen, K., Fuernau, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208410 · Cited by 2,861
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940 · cited 1×
“In a randomized study comparing dopamine and norepinephrine (8), a subgroup analysis of 280 patients with CS found that dopamine was associated with increased 28-day mortality compared with norepinephrine, leading to a progressive decrease in dopamine use in this indication (9).”
van Diepen, S., Katz, J. N., Albert, N. M., Henry, T. D., Jacobs, A. K., Kapur, N. K., Kilic, A., Menon, V., Ohman, E. M., Sweitzer, N. K., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000525 · Cited by 1,869
Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients
Hayes, M. A., Timmins, A. C., Yau, E., Palazzo, M., Hinds, C. J., & Watson, D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302404 · Cited by 1,538
PCI strategies in patients with acute myocardial infarction and cardiogenic shock
Thiele, H., Akin, I., Sandri, M., Fuernau, G., de Waha, S., Meyer-Saraei, R., Nordbeck, P., Geisler, T., Landmesser, U., Skurk, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1710261 · Cited by 1,209
Regulation of coronary blood flow during exercise
Duncker, D. J., & Bache, R. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00045.2006 · Cited by 936
Ouweneel, D. M., Eriksen, E., Sjauw, K. D., van Dongen, I. M., Hirsch, A., Packer, E. J. S., Vis, M. M., Wykrzykowska, J. J., Koch, K. T., Baan, J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.022 · Cited by 890
Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic Shock
Harjola, V.-P., Lassus, J., Sionis, A., Køber, L., Tarvasmäki, T., Spinar, J., Parissis, J., Banaszewski, M., Silva-Cardoso, J., Carubelli, V., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.260 · Cited by 790
Self-citationAnnane, D., Vignon, P., Renault, A., Bollaert, P.-E., Charpentier, C., Martin, C., Troché, G., Ricard, J.-D., Nitenberg, G., Papazian, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61344-0 · Cited by 567
Self-citationLactate is an unreliable indicator of tissue hypoxia in injury or sepsis
James, J. H., Luchette, F. A., McCarter, F. D., & Fischer, J. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)91132-1 · Cited by 538
Levy, B., Gibot, S., Franck, P., Cravoisy, A., & Bollaert, P.-E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71045-x · Cited by 506
Self-citationLevy, B., Bollaert, P.-E., Charpentier, C., Nace, L., Audibert, G., Bauer, P., Nabet, P., & Larcan, A. (1997) · Intensive Care Medicine · doi:10.1007/s001340050329 · Cited by 444
Self-citationSakr, Y., Reinhart, K., Vincent, J.-L., Sprung, C. L., Moreno, R., Ranieri, V. M., De Backer, D., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201896.45809.e3 · Cited by 404
Vasopressors for hypotensive shock
Gamper, G., Havel, C., Arrich, J., Losert, H., Pace, N. L., Müllner, M., & Herkner, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub4 · Cited by 239
for the Canadian Critical Care Trials Group., Lamontagne, F., Meade, M. O., Hébert, P. C., Asfar, P., Lauzier, F., Seely, A. J. E., Day, A. G., Mehta, S., Muscedere, J., et al. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4237-3 · Cited by 230
Levy, B., Desebbe, O., Montemont, C., & Gibot, S. (2008) · Shock · doi:10.1097/shk.0b013e318167378f · Cited by 223
Self-citationfor the CardShock study investigators, Tarvasmäki, T., Lassus, J., Varpula, M., Sionis, A., Sund, R., Køber, L., Spinar, J., Parissis, J., Banaszewski, M., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1387-1 · Cited by 203
Self-citationExperts’ recommendations for the management of adult patients with cardiogenic shock
Levy, B., Bastien, O., Bendjelid, K., Cariou, A., Chouihed, T., Combes, A., Mebazaa, A., Megarbane, B., Plaisance, P., Ouattara, A., et al. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0052-1 · Cited by 172
Self-citationFrancis, G. S., Bartos, J. A., & Adatya, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.016 · Cited by 172
Heubach, J. F., Ravens, U., & Kaumann, A. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1313 · Cited by 144
Lorusso, R., Gelsomino, S., Parise, O., Mendiratta, P., Prodhan, P., Rycus, P. T., MacLaren, G., Brogan, T. V., Chen, Y., Maessen, J. G., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.10.023 · Cited by 125
Lévy, B., Mansart, A., Montémont, C., Gibot, S., Mallié, J.-P., Regnault, V., Lecompte, T., & Lacolley, P. J. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0523-9 · Cited by 102
Lactate and lactate clearance in acute cardiac care patients
Attanà, P., Lazzeri, C., Picariello, C., Dini, C. S., Gensini, G. F., & Valente, S. (2012) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872612451168 · Cited by 89
Biased β2‐adrenoceptor signalling in heart failure: pathophysiology and drug discovery
Woo, A. Y., Song, Y., Xiao, R., & Zhu, W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12965 · Cited by 73
Perez, P., Kimmoun, A., Blime, V., & Lévy, B. (2014) · Shock · doi:10.1097/shk.0000000000000099 · Cited by 70
Self-citationFuernau, G. F., Poenisch, C., Eitel, I., de Waha, S., Desch, S., Schuler, G. C., Adams, V., Werdan, K., Zeymer, U., & Thiele, H. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.117 · Cited by 64
Møller, M. H., Claudius, C., Junttila, E., Haney, M., Oscarsson‐Tibblin, A., Haavind, A., & Perner, A. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12780 · Cited by 61
Detailing the cardiovascular profile in shock patients
Backer, D. D. (2017) · Critical Care · doi:10.1186/s13054-017-1908-6 · Cited by 51
Pharmacologic therapies for acute cardiogenic shock
Nativi-Nicolau, J. N., Selzman, C. H., Fang, J. C., & Stehlik, J. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000057 · Cited by 45
Jeger, R. V., Lowe, A. M., Buller, C. E. H., Pfisterer, M. E., Džavík, V., Webb, J. G., Hochman, J. S., & Jorde, U. P. (2007) · CHEST Journal · doi:10.1378/chest.07-1336 · Cited by 36
Vasopressors for acute myocardial infarction complicated by cardiogenic shock
Prondzinsky, R., Hirsch, K., Wachsmuth, L., Buerke, M., & Unverzagt, S. (2017) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-017-0378-6 · Cited by 4
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationHeidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Self-citationNolan, J. P., Sandroni, C., Böttiger, B. W., Cariou, A., Cronberg, T., Friberg, H., Genbrugge, C., Haywood, K., Lilja, G., Moulaert, V. R. M., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06368-4 · Cited by 1,078
Self-citation
Metadata
- Authors
- Levy, B., Clere-Jehl, R., Legras, A., Morichau-Beauchant, T., Leone, M., Frederique, G., Quenot, J.-P., Kimmoun, A., Cariou, A., Lassus, J., Harjola, V.-P., Meziani, F., Louis, G., Rossignol, P., Duarte, K., Girerd, N., Mebazaa, A., Vignon, P., Mattei, M., Thivilier, C., Perez, P., Auchet, T., Fritz, C., Boisrame-Helme, J., Mercier, E., Garot, D., Perny, J., Gette, S., Hammad, E., Vigne, C., Dargent, A., Andreu, P., & Guiot, P.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 72
- Issue
- 2
- Pages
- 173-182
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2810324481
- Cited by
- 477
- References
- 32
- FWCI
- 16.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.